Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice
2006

Cortactin's Role in Breast Tumor Development in Mice

Sample size: 100 publication Evidence: moderate

Author Information

Author(s): Agnes G. van Rossum, Maaike P. van Bragt, Ellen Schuuring-Scholtes, Jan C. M. van der Ploeg, Johan H. J. M. van Krieken, Philip M. Kluin, Ed Schuuring

Primary Institution: Leiden University Medical Center

Hypothesis

Does overexpression of human cortactin in mammary glands affect tumor development in mice?

Conclusion

The study concludes that overexpression of human cortactin does not increase the development of breast tumors in mice.

Supporting Evidence

  • Cortactin overexpression did not lead to an increased incidence of breast tumors in transgenic mice.
  • The incidence of tumors in MMTV-cortactin mice was lower than in wild-type controls.
  • Histological analysis showed no significant differences in tumor types between transgenic and wild-type mice.

Takeaway

The researchers wanted to see if a protein called cortactin could help mice develop breast tumors, but it turns out it didn't help at all.

Methodology

Transgenic mice were created and analyzed for tumor development through various breeding and histological examinations.

Potential Biases

Potential bias due to the specific inbred mouse strain used, which may not represent broader populations.

Limitations

The study's findings may be influenced by the genetic background of the mice and the long latency period for tumor development.

Participant Demographics

Female mice from the FVB/N inbred strain were used in the study.

Statistical Information

P-Value

0.034

Statistical Significance

p=0.034

Digital Object Identifier (DOI)

10.1186/1471-2407-6-58

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication